Superpower vs Hims vs Peptide Clinics: Where to Get Peptides in 2026

If you want skin that looks ten years younger, faster workout recovery, or real body recomposition, injectable peptides like BPC-157 and GHK-Cu are the standard you keep hearing about. But right now, figuring out who can legally write the prescription and ship the vial is a confusing mess of policy changes, corporate buyouts, and telehealth promises.

Here is the quick verdict: as of August 2026, no major consumer telehealth platform has published peptide pricing yet. The Food and Drug Administration advisory panel backed six peptides for pharmacy compounding in late July 2026, but final rules are still pending. Hims is best positioned to launch first because it already bought dedicated compounding facilities. Superpower explicitly does not offer injectable peptides today. For now, private medical practices and specialized clinics remain the main setting where prescribers evaluate patients for customized compounded therapies.

Take the Quiz First: Your Personalized Peptide Plan

Before comparing telehealth giants or booking clinic consultations, you need to know which compounds match your specific aesthetic and metabolic goals.

1. The Get Hot or Die Plan: The starting point. It identifies whether you need tissue-repair peptides like BPC-157, the copper peptide GHK-Cu for skin firming and hair density, or secretagogues that prompt your body to make more natural growth hormone, then matches you with the right provider model based on your state and timeline.
2. Hims / Hers: The frontrunner for mass-market convenience once final FDA compounding rules take effect. Best for readers who want an all-in-one digital subscription with an integrated pharmacy.
3. Independent Peptide Clinics: The current hands-on route for in-depth evaluations. Best for tailored dosing, comprehensive bloodwork panels, and direct clinical oversight from an MD or specialized nurse practitioner.
4. Superpower: High-end longevity lab testing and preventative medicine platform. Best for tracking deep health biomarkers, hormone support, and using topical or oral peptides, but not currently a provider of injectable peptides.

Matching the compound to your baseline prevents you from overpaying for clinic packages you do not need. Take the quiz to find your personalized peptide plan and see which compounds fit your goals.

What Actually Changed in July 2026

The legal landscape around peptides moved fast throughout the spring and summer of 2026. Understanding where the rules stand helps you avoid illegal sources and spot when legitimate telehealth prescribing opens up.

In September 2023, the FDA placed dozens of popular peptides onto its Category 2 list, a classification for bulk drug substances that raised safety questions, effectively halting legal 503A compounding. That shifted on April 15, 2026, when health officials announced plans to re-evaluate them. On April 23, 2026, twelve peptides came off the Category 2 list and were scheduled for formal scientific review.

On July 23 and 24, 2026, the FDA Pharmacy Compounding Advisory Committee (PCAC) held public meetings to evaluate seven popular peptides. The committee voted to recommend six of them, including BPC-157 and GHK-Cu, for addition to the 503A Bulk Drug Substances List.

A 503A pharmacy is a state-licensed compounding pharmacy that prepares customized medications directly for an individual patient based on a valid prescription. While the PCAC vote was a major step forward, physicians are not permitted to prescribe, and pharmacies are not permitted to prepare, these medications under the standard bulks list until the FDA publishes its final rule in the Federal Register. Like most research peptides, injectable GHK-Cu and BPC-157 are not commercially FDA-approved finished drug products sold in standard retail pharmacies. That distinction is why legal access depends entirely on the compounding framework.

Superpower vs Hims vs Independent Peptide Clinics Compared

Choosing where to get peptides comes down to pharmacy infrastructure, prescriber access, and whether the provider can legally ship an injectable compound to your door.

Feature	The Get Hot or Die Plan	Hims & Hers	Independent Peptide Clinics	Superpower
Current Injectable Status	Personalized Provider Match	Pending post-vote rollout	Clinical intake model	Not offered (as of August 2026)
Pharmacy Model	503A / 503B vetted network	In-house 503A & 503B facilities	External 503A partner pharmacies	Partner labs (diagnostics only)
Prescriber Type	Licensed MD, DO, or NP	Telehealth network NP / MD	In-person or telehealth MD / NP	Longevity-focused MD network
Required Testing	Goal-matched baseline labs	Basic online medical intake	Full baseline blood panel	Comprehensive whole-body testing
Pricing Transparency	Upfront tier estimates	Subscription model (TBD)	Clinic-dependent (TBD)	Membership + lab package
Best For	Finding your exact compound match	Fast, cheap convenience once live	High-touch plans & supervision	Preventive health & data tracking

Why Hims Bought Compounding Pharmacies Before the Vote

While competitors waited for regulatory clarity, Hims spent late 2024 and 2025 building physical manufacturing infrastructure. The company acquired 503A compounding pharmacies in Ohio and Arizona, along with a 503B sterile manufacturing facility in California. In February 2025, Hims purchased a dedicated peptide manufacturing facility in California.

A 503B outsourcing facility is held to Current Good Manufacturing Practice (CGMP) standards, the same high-level sterility and validation regulations that brand-name pharmaceutical companies follow. Under Section 503B of the Federal Food, Drug, and Cosmetic Act, these facilities can compound sterile batches for clinical distribution.

Owning this infrastructure gives Hims complete vertical integration. Instead of relying on third-party compounders, Hims can formulate its own peptide vials, test them in-house, and ship them directly to consumers under state pharmacy licenses. When the final FDA rule takes effect, Hims has the physical supply chain ready to launch lower-cost peptide subscriptions almost overnight.

What Superpower Actually Offers Right Now

Superpower has established a major presence in preventative medicine, whole-body biomarker testing, and longevity health. However, as of August 2026, Superpower explicitly states on its clinical platform that it does not offer injectable peptides.

Superpower focuses on detailed diagnostic testing, digital health tracking, oral supplementation, and topical peptide formulations. If you join Superpower expecting a vial of injectable BPC-157 or subcutaneous GHK-Cu, you will not receive one. Any injectable peptide access requires a licensed prescriber and a state-licensed compounding pharmacy operating under applicable state and federal guidelines.

Superpower is a valuable platform for getting comprehensive bloodwork, tracking inflammatory markers, and monitoring your biological baseline. But it is not a direct dispensary for injectable peptide plans.

Independent Peptide Clinics: What to Look For and What to Avoid

Until large telehealth platforms turn on their peptide prescribing funnels, independent medical practices and specialized integrative clinics remain the primary setting for peptide evaluations.

A qualified clinic should meet these non-negotiable standards:

• A Licensed Prescriber: Your intake must be conducted by a licensed Medical Doctor (MD), Doctor of Osteopathic Medicine (DO), Nurse Practitioner (NP), or Physician Assistant (PA) who reviews your medical history.
• Baseline Blood Panels: A reputable practitioner will check kidney function, liver enzymes, and relevant hormone or metabolic markers before prescribing injectable compounds.
• 503A Compounding with PCAB Accreditation: Your prescription should be routed to a state-licensed 503A compounding pharmacy. Look for accreditation from the Pharmacy Compounding Accreditation Board (PCAB), which verifies compliance with United States Pharmacopeia (USP) Chapter 797 standards for sterile preparations.
• Structured Follow-Up: The clinic must provide clear injection instructions, safe needle disposal, and scheduled check-ins to monitor your progress and adjust doses.

Avoid any website selling unconstituted powder labeled "for research use only" or "not for human consumption." These sellers bypass pharmacy licensing, do not verify sterile compounding standards, and carry serious safety risks. A legitimate medical pathway always provides a patient-specific prescription bottle or sterile vial with your name and exact dosage instructions on the pharmacy label.

What Prescription Peptides Will Actually Cost

Because mainstream platforms have not published official price lists as of August 2026, exact figures across the industry remain unconfirmed. Any specific dollar number you see online is market speculation. However, understanding the structural cost layers helps you evaluate future offers.

Compounded prescription peptides carry legitimate medical overhead that unregulated research vials do not:

• Clinical Consultations: Time and medical review from a licensed MD, DO, or NP.
• Sterility and Batch Testing: Rigorous release testing required for sterile injectable preparations under USP standards.
• Licensed Cold-Chain Logistics: Temperature-controlled shipping under individual state pharmacy board licenses.
• Administrative and Refill Oversight: Ongoing dosage adjustments, clinical messaging, and refill reviews.

When mass-market telehealth platforms like Hims launch their bundled plans, integrated pharmacy manufacturing is expected to streamline these cost layers compared to boutique, low-volume private practices.

What to Do Right Now While Pricing Shakes Out

You do not need to wait on the sidelines while corporate telehealth platforms finalize their pharmacy rollouts.

First, get your baseline labs done so you have objective data on your metabolic health, liver function, and systemic inflammation. Second, start using high-potency topical GHK-Cu skincare, which delivers noticeable benefits for skin elasticity and fine lines without requiring an injection. Finally, take the peptide quiz to organize your aesthetic and physical goals, learn which compounds fit your needs, and prepare for the upcoming commercial rollout.

Frequently Asked Questions

Can I actually get BPC-157 or GHK-Cu prescribed right now in 2026?

Not through standard nationwide retail compounding yet. While the FDA Advisory Committee voted in July 2026 to recommend six peptides for the 503A Bulks List, prescribers and compounding pharmacies must wait for the FDA to issue its final published rule in the Federal Register before routine 503A commercial dispensing officially begins.

Is Hims going to sell peptides and when?

Hims is expected to launch peptide subscriptions once the FDA finalizes rulemaking following the July 2026 PCAC recommendations. Hims already acquired 503A compounding pharmacies in Ohio and Arizona, a 503B sterile manufacturing facility, and a dedicated peptide manufacturing plant in California to prepare for nationwide distribution.

Does Superpower prescribe injectable peptides?

No. As of August 2026, Superpower explicitly states on its platform that it does not offer injectable peptides. The platform provides comprehensive diagnostics, longevity tracking, and topical or oral wellness options.

What is the difference between a 503A and 503B compounding pharmacy?

A 503A pharmacy compounds medications for individual patients based on a specific prescription and complies with state pharmacy board rules and USP 797 sterile standards. A 503B outsourcing facility manufactures larger batches of sterile products under federal Current Good Manufacturing Practice (CGMP) regulations, the same standards applied to traditional pharmaceutical manufacturers.

Are "research use only" peptides safe to use?

No. Peptides labeled "for research use only" or "not for human consumption" are sold outside the regulated medical system. They lack patient-specific medical oversight, verified sterile batch testing, and legal compounding protections.

How much will compounded peptides cost through telehealth?

As of August 2026, no major telehealth platform has published official peptide pricing, so any specific dollar figure is speculation. Compounded prescriptions reflect real medical costs, including licensed prescriber reviews, sterile pharmacy batch testing, and temperature-controlled shipping.

What does PCAB accreditation mean and why should I care?

PCAB (Pharmacy Compounding Accreditation Board) accreditation is an independent quality credential proving that a compounding pharmacy meets the highest national standards for sterile preparation, ingredient purity, and regulatory compliance under USP 797 guidelines.

Do I need bloodwork before starting peptides?

Yes. A responsible prescriber will review baseline kidney function, liver enzymes, and relevant metabolic markers before issuing a prescription to confirm that peptide therapy is safe and appropriate for your body.

Which peptides were included in the July 2026 FDA advisory vote?

The FDA Pharmacy Compounding Advisory Committee reviewed seven peptides during its July 23-24, 2026 public meeting and voted to recommend six of them, including tissue-repair and anti-aging favorites like BPC-157 and GHK-Cu, for inclusion on the 503A Bulk Drug Substances List.

Can a nurse practitioner prescribe peptides or does it have to be an MD?

In most states, licensed Advanced Practice Registered Nurses (APRNs or NPs) and Physician Assistants (PAs) have full or collaborative prescribing authority to evaluate patients and write prescriptions to licensed compounding pharmacies.